← Russell 3000 cross-section

RCEL AVITA Medical, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-06, not restated
Healthcare

Scale

Market cap
$323m
Revenue TTM
$76m
Net income TTM
$-43m
Free cash flow
$-25m
Composite score
Sector rank
#2619

Valuation

P / E
EV / EBITDA
EV / sales
4.1
FCF yield
-7.63%
Earnings yield vs 10-yr
-18.09pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-57.0%
EBITDA margin
-43.2%
ROE
154.8%
ROIC
Revenue growth
1.0%

Insider activity, last 90 days

Net open-market
$0.19m
Buyers
1
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

There remains significant uncertainty in the current macroeconomic environment due to factors including supply chain shortages, increased cost of healthcare, changes to inflation rates, a competitive labor market, tariffs, and other related global economic and geopolitical conditions. The table below summarizes the results of our operations for each of the periods presented (in thousands). *nm = not meaningful Total revenues increased by 18%, or $3.3 million, to approximately $21.7 million, compared to $18.4 million in the same period in the prior year. …AVITA Medical, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-06

Read the full passage →